 |
|
Recent research trends and updates on nonalcoholic fatty liver disease
Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn,
Clin Mol Hepatol. 2019;25(1):1-11. Published online 2018 Aug 8 DOI: https://doi.org/10.3350/cmh.2018.0037
|
|
Citations to this article as recorded by
 Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin
Current Drug Therapy.2024; 19(1): 20. CrossRef Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases
Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee
Biomolecules.2024; 14(3): 277. CrossRef Three-Step Algorithm for Screening High-Risk Group of Metabolic Dysfunction-Associated Steatotic Liver Disease in General Population
Joo Hyun Oh, Dae Won Jun
Gut and Liver.2024; 18(2): 197. CrossRef Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers
Francesca Terracciani, Andrea Falcomatà, Paolo Gallo, Antonio Picardi, Umberto Vespasiani-Gentilucci
Journal of Physiology and Biochemistry.2023; 79(4): 851. CrossRef Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia
Joon Ho, Eunhwa Kim, Myeongjee Lee, Inkyung Jung, Young Suk Jo, Jandee Lee
Scientific Reports.2023;[Epub] CrossRef Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
Clinical and Molecular Hepatology.2023; 29(Suppl): S32. CrossRef Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria
Jie Pan, Yijie Ding, Yan Sun, Qiuyan Li, Tianyi Wei, Yingying Gu, Yujia Zhou, Nengzhi Pang, Lei Pei, Sixi Ma, Mengqi Gao, Ying Xiao, De Hu, Feilong Wu, Lili Yang
Journal of Clinical Medicine.2023; 12(6): 2126. CrossRef Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Sang Bong Ahn
Clinical and Molecular Hepatology.2023; 29(Suppl): S150. CrossRef Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus
Qian Gao, Lei Feng, Weiling Zhou, Xiaoli Li, Lanzi Yin, Yuan Wang
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2345. CrossRef Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review
Mah I Kan Changez, Maryam Mubeen, Monezahe Zehra, Inara Samnani, Aniqa Abdul Rasool, Anmol Mohan, Um Ul Wara, Usha Tejwaney, Vikash Kumar
Journal of International Medical Research.2023;[Epub] CrossRef Association between PNPLA3 and TM6SF2 gene polymorphisms and non-alcoholic fatty liver disease patients in Kazakhstan
Ainura Amirkulova, Gulmira Derbissalina, Valeriy Benberin, Nasrulla Shanazarov, Gulshara Abildinova, Doskhan Kozhakhmet, Helena Katchman
Electronic Journal of General Medicine.2023; 20(6): em546. CrossRef The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis
Maryam K. Ibrahim, Robert M. Wilechansky, Prasanna K. Challa, Xuehong Zhang, Edward Giovannucci, Meir Stampfer, Andrew T. Chan, Tracey G. Simon
Hepatology Communications.2023;[Epub] CrossRef Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease
Apostolis PAPAEFTHYMIOU, Michael DOULBERIS, Kyriaki KARAFYLLIDOU, Eleftherios CHATZIMICHAEL, Georgia DERETZI, Aristomenis K. EXADAKTYLOS, Fotios SAMPSONAS, Athanasios GELASAKIS, Spyros I. PAPAMICHOS, Georgios KOTRONIS, Dimitra GIALAMPRINOU, Elisabeth VARD
Minerva Endocrinology.2023;[Epub] CrossRef The experience of the "Nicolae Malaxa" Clinical Hospital Bucharest, 2021-2022: non-alcoholic hepatic steatosis – etiological and risk profile
Gabriela-Carmen Obilişteanu, Alexandru-Mihai Ştefănescu, Florin-Mihai Lungana, Nicolae Runcanu
Medic.ro.2023; 5(155): 8. CrossRef Molecular Docking Study of Phytosterols in Lygodium microphyllum Towards SIRT1 and AMPK, the in vitro Brine Shrimp Toxicity Test, and the Phenols and Sterols Levels in the Extract
Putri Anggreini, Hadi Kuncoro, Sri Sumiwi, Jutti Levita
Journal of Experimental Pharmacology.2023; Volume 15: 513. CrossRef Both full length‐cholesteryl ester transfer protein and exon 9‐deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes
Yan Liu, Daniel Mihna, Lahoucine Izem, Richard E. Morton
Lipids.2022; 57(1): 69. CrossRef Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis
Mi Na Kim, Chun-Han Lo, Kathleen E. Corey, Xiao Luo, Lu Long, Xuehong Zhang, Andrew T. Chan, Tracey G. Simon
Clinical Nutrition.2022; 41(2): 356. CrossRef Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Diabetologia.2022; 65(3): 518. CrossRef Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma
Mizelle D'Silva, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Moonhwan Kim
Surgical Oncology.2022; 41: 101730. CrossRef MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
Young-Sun Lee, Ji Eun Lee, Hyon-Seung Yi, Young Kul Jung, Dae Won Jun, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Baek-hui Kim, Jeong Woo Kim, Chang Hee Lee, Jong Eun Yeon, Juneyoung Lee, Soon Ho Um, Kwan Soo Byun
Hepatology International.2022; 16(2): 316. CrossRef DNA Methylation Patterns According to Fatty Liver Index and Longitudinal Changes from the Korean Genome and Epidemiology Study (KoGES)
Young Kyung Ko, Hayeon Kim, Yoonseok Lee, Young-Sun Lee, Jeong-An Gim
Current Issues in Molecular Biology.2022; 44(3): 1149. CrossRef Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
Yuna Kim, Eugene Han, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Mi Kyung Kim, Hye Soon Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee, Seung Up Kim
Gut and Liver.2022; 16(2): 290. CrossRef Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study
Chan-Young Jung, Ho Soo Chun, Minjong Lee, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim
Diabetes & Metabolism.2022; 48(5): 101362. CrossRef Tenofovir alafenamide alleviates nonalcoholic steatohepatitis in mice by blocking the phosphorylation of AKT in intrahepatic mononuclear phagocytes
Pu Reun Roh, Sung Min Kim, Byung-Yoon Kang, Kyoung Do Mun, Jong Geun Park, Min Woo Kang, Wonhee Hur, Ji Won Han, Heechul Nam, Seung Kew Yoon, Pil Soo Sung
Biomedicine & Pharmacotherapy.2022; 156: 113952. CrossRef Environmental exposure to organophosphate esters and suspected non-alcoholic fatty liver disease among US adults: A mixture analysis
Haisheng Chai, Weiye Hu, Yaoyao Dai, Xiaohan Zhu, Ping'an Qian, Junfeng Zhu
Frontiers in Public Health.2022;[Epub] CrossRef A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
Deyao Zhang, Yangxun Pan, Zhenyun Yang, Huilan Zeng, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Minshan Chen, Dandan Hu
Journal of Clinical Medicine.2022; 12(1): 324. CrossRef Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation
Ju Won Lee, Seung Ha Park
Journal of Affective Disorders.2021; 278: 259. CrossRef Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years
Hye Won Lee, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Diabetes and its Complications.2021; 35(1): 107747. CrossRef Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clinical and Molecular Hepatology.2021; 27(1): 44. CrossRef Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes
Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Young Dae Kim, Seung Up Kim
Journal of Gastroenterology and Hepatology.2021; 36(6): 1703. CrossRef From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee
Clinical and Molecular Hepatology.2021; 27(2): 257. CrossRef Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Tracey G. Simon, Andrew T. Chan, Seong Gyu Hwang
Scientific Reports.2021;[Epub] CrossRef Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
Jin Won Chang, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Gut and Liver.2021; 15(1): 117. CrossRef Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
Kwang Min Kim, Ji-Hye Roh, Sangjin Lee, Jeong-Hyun Yoon
Scientific Reports.2021;[Epub] CrossRef Nonalcoholic Fatty Liver Disease: A Global Perspective
Wei-Kei Wong, Wah-Kheong Chan
Clinical Therapeutics.2021; 43(3): 473. CrossRef Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
Min-Kyu Kang, Jung-Hun Baek, Young-Oh Kweon, Won-Young Tak, Se-Young Jang, Yu-Rim Lee, Keun Hur, Gyeonghwa Kim, Hye-Won Lee, Man-Hoon Han, Joon-Hyuk Choi, Soo-Young Park, Jung-Gil Park
Diagnostics.2021; 11(6): 1061. CrossRef Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
Tae Hyung Kim, Yoonseok Lee, Young-Sun Lee, Jeong-An Gim, Eunjung Ko, Sun Young Yim, Young Kul Jung, SeongHee Kang, Moon Young Kim, Hayeon Kim, Baek-hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Scientific Reports.2021;[Epub] CrossRef Inhaled exposure to air fresheners aggravated liver injury in a murine model of nonalcoholic fatty acid liver disease
Sanghwa Kim, Ah Young Lee, Myung-Haing Cho
Heliyon.2021; 7(3): e06452. CrossRef Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
Min-Kyu Kang, Jung-Gil Park
Diagnostics.2021; 11(5): 854. CrossRef Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim
Scientific Reports.2021;[Epub] CrossRef Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clinical and Molecular Hepatology.2021; 27(1): 87. CrossRef Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression
Jeong-An Gim, Soo Min Bang, Young-Sun Lee, Yoonseok Lee, Sun Young Yim, Young Kul Jung, Hayeon Kim, Baek-Hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun, Matias A. Avila
PLOS ONE.2021; 16(8): e0255822. CrossRef Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
Jung Gil Park, Jinho Jung, Kritin K. Verma, Min Kyu Kang, Egbert Madamba, Scarlett Lopez, Aed Qas Yonan, Amy Liu, Ricki Bettencourt, Claude Sirlin, Rohit Loomba
Alimentary Pharmacology & Therapeutics.2021; 53(9): 1030. CrossRef Systematic review with meta‐analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma
Daryl Ramai, Jameel Singh, Janice Lester, Shahab R. Khan, Saurabh Chandan, Nicola Tartaglia, Antonio Ambrosi, Gaetano Serviddio, Antonio Facciorusso
Alimentary Pharmacology & Therapeutics.2021; 53(9): 977. CrossRef Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women
S. H. Park, Y. E. Park, J. Lee, J. H. Choi, N. Y. Heo, J. Park, T. O. Kim, Y. S. Moon, H. K. Kim, H. J. Jang, H. Y. Park, C.-H. Jeong, K. T. Suk, D. J. Kim
Climacteric.2020; 23(2): 173. CrossRef Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim
Clinical and Molecular Hepatology.2020; 26(2): 209. CrossRef Liver involvement in patients with Gaucher disease types I and III
Rodrigo Tzovenos Starosta, Filippo Pinto e Vairo, Alícia Dorneles Dornelles, Suélen Porto Basgalupp, Marina Siebert, Maria Lúcia Alves Pedroso, Carlos Thadeu Schmidt Cerski, Mário Reis Álvares-da-Silva, Ida Vanessa Doederlein Schwartz
Molecular Genetics and Metabolism Reports.2020; 22: 100564. CrossRef Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators
Seung Ha Park, Dong Joon Kim, Lindsay D. Plank
European Journal of Clinical Nutrition.2020; 74(10): 1401. CrossRef Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017
Mi Jin Kim, Kyung Jae Lee
BMC Pediatrics.2020;[Epub] CrossRef Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease
Young-Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, In Hee Kim, Soo Yeon Lee, Baek-Hui Kim, Jeong Woo Kim, Chang Hee Lee, Jong Eun Yeon, So Young Kwon, Soon Ho Um, Kwan Soo Byun
Clinical and Translational Gastroenterology.2020; 11(4): e00157. CrossRef Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
Soung Won Jeong
Clinical and Molecular Hepatology.2020; 26(2): 185. CrossRef Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
Hyuk Soo Eun
Clinical and Molecular Hepatology.2020; 26(2): 236. CrossRef Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database
Boram Cha, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee
Scientific Reports.2020;[Epub] CrossRef Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Seon Young Ahn, Suk Bae Kim, Il Han Song
Canadian Journal of Gastroenterology and Hepatology.2020; 2020: 1. CrossRef Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years
Young Chang, Jun Il Kim, Bora Lee, Sang Gyune Kim, Min Jung Jung, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Jeong-Ju Yoo
Clinical and Molecular Hepatology.2020; 26(3): 318. CrossRef Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study
Bertha Araceli Marin-Alejandre, Itziar Abete, J. Ignacio Monreal, Mariana Elorz, Alberto Benito-Boillos, José Ignacio Herrero, Iñigo Navarro-Blasco, Josep A. Tur, Narcisa M. Bandarra, M. Angeles Zulet, J. Alfredo Martinez
Journal of Clinical Lipidology.2020; 14(6): 837. CrossRef Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Min Kyu Kang, Jung Gil Park, Min Cheol Kim
Yonsei Medical Journal.2020; 61(10): 860. CrossRef Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
Jung Gil Park, Gyeonghwa Kim, Se Young Jang, Yu Rim Lee, Eunhye Lee, Hye Won Lee, Man-Hoon Han, Jae Min Chun, Young Seok Han, Jun Sik Yoon, Min Kyu Kang, Young Oh Kweon, Won Young Tak, Soo Young Park, Keun Hur
Life.2020; 10(10): 230. CrossRef Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women
Mi Na Kim, Chun-Han Lo, Kathleen E. Corey, Po-Hong Liu, Wenjie Ma, Xuehong Zhang, Manol Jovani, Mingyang Song, Andrew T. Chan, Tracey G. Simon
Metabolism.2020; 113: 154398. CrossRef Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming
Soung Won Jeong
Diabetes & Metabolism Journal.2020; 44(5): 640. CrossRef Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang
Digestive Diseases.2020; 38(6): 507. CrossRef Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
Metabolism.2019; 92: 82. CrossRef Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans
Kan Chen, Jianbo Ma, Xiaoyuan Jia, Wen Ai, Zhongren Ma, Qiuwei Pan
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2019; 1871(1): 117. CrossRef Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B
Beom Kyung Kim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2019; 50(3): 333. CrossRef Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee
PLOS ONE.2019; 14(10): e0223678. CrossRef The evaluation of complications and mortality in non-alcoholic steatohepatitis-related cirrhosis
Sezgin VATANSEVER, Zehra Betül PAKÖZ
Marmara Medical Journal.2019; 32(1): 44. CrossRef
|